IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: Improved control of Trypanosoma cruzi infection

Clinical and Experimental Immunology

Volumn 113, Issue 1, 1998, Pages 59-64

  Jacobs, F ^a,b   Chaussabel, D ^a   Truyens, C ^a   Leclerq, V ^a   Carlier, Y ^a   Goldman, M ^a   Vray, B ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

IL 10; Lipopolysaccharide; Macrophages; Nitric oxide; Trypanosoma cruzi

Indexed keywords

LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; INFECTION CONTROL; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTOZOAL INFECTION; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; TRYPANOSOMA CRUZI; UP-REGULATION;

EID: 0031873471     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00637.x     Document Type: Article

References (43)

1. MacMicking J, Xie Q-W, Nathan C. Nitric oxide and macrophage function. Ann Rev Immunol 1997; 15:323-50.
2. James SL. Role of nitric oxide in parasitic infections. Microbiol Rev 1995; 59:533-47.
3. Hamilton TA, Adams DO. Molecular mechanisms of signal transduction in macrophages. Immunol Today 1987; 8:151-8.
4. Jorens PG, Matthys KE, Bult H. Modulation of nitric oxide synthase activity in macrophages. Med Inflammation 1995; 4:75-89.
5. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174:1549-55.
6. de Waal Malefyt R, Abrams J, Bennett B et al. Interleukin 10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1992; 174:1209-20.
7. Chesrown SE, Monnier J, Visner G et al. Regulation of inductible nitric oxide synthase mRNA levels by LPS. IFN-γ, TGF-β, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem Biophys Res Commun 1994; 200:126-34.
8. Loftis LL, Meals EA, English BK. Differential effects of pentoxifylline and interleukin-10 on production of tumor necrosis factor and inductible nitric oxide synthase by murine macrophages. J Infect Dis 1997; 175:1008-11.
9. Perretti M, Szabo C, Thiemermann C. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br J Pharmacol 1995; 116:2251-7.
10. Berg DJ, Kuhn R, Rajewsky K et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 1995; 96:2339-47.
11. Nemoto Y, Otsuka T, Niiro H et al. Inhibitory effects of interleukin-10 and viral IL-10 on the functions of monocytes/macrophages. Nihon Rinsho Meneki Gakkai-Kaishi 1995; 18:152-9.
12. Gérard C, Bruyns C, Marchant A et al. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177:547-50.
13. Mosmann TR, Scumacher JH, Fiorentino DF et al. Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2 specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. J Immunol 1990; 145:38-45.
14. Olivares FE, Heirman C, Thielemans K et al. Granulocyte-macrophage colony-stimulating factor: involvement in control of Trypanosoma cruzi infection in mice. Infect Immun 1996; 64:3429-34.
15. El Bouhdidi A, Truyens C, Rivera M-T et al. Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinaemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies. Parasite Immunol 1994; 16:69-76.
16. Dentener MA, Greve JW, Maessen JG et al. Role of tumor necrosis factor in the phenomenon of the enhanced sensitivity of animals to endotoxin after exposition to lead. Immunopharmacol Immunotoxicol 1989; 11:321-4.
17. 15N] nitrate in biological fluids. Anal Biochem 1982; 126:131-8.
18. Chen WF, Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 1991; 147:528-34.
19. Carson WE, Lindemann MJ, Baiocchi R et al. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 1995; 85:3577-85.
20. Yang G, Hellström KE, Mizuno MT et al. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation. J Immunol 1995; 155:3897-903.
21. Zheng LM, Ojcius DM, Garaud F et al. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J Exp Med 1996; 184:579-84.
22. te Velde AA, de Waal Malefijt R, Huijbens RJF et al. IL-10 stimulates monocytes FcγR surface expression and cytotoxic activity. J Immunol 1992; 149:4048-52.
23. Corradin SB, Fasel N, Buchmüller-Rouiller Y et al. Induction of macrophage nitric oxide production by interferon-γ and tumor necrosis factor-α is enhanced by interleukin-10. Eur J Immunol 1993; 23:2045-8.
24. Appelberg R. Opposing effects of interleukin-10 on mouse macrophage functions. Scand J Immunol 1995; 41:539-44.
25. van der Poll T, Marchand A, Keogh CV et al. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 1996; 174:994-1000.
26. Cusumano V, Genovese F, Mancuso G et al. Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect Immun 1996; 64:2850-2.
27. Yang X, HayGlass KT, Brunham RC. Genetically determined differences in IL-10 and IFN-γ responses correlate with clearance of Chlamydia trachomatis mouse peritonitis infection. J Immunol 1996; 156:4338-44.
28. Greenberger MJ, Strieter RM, Kunkel SL et al. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 1995; 155:722-9.
29. Arai T, Hiromatsu K, Nishimura H et al. Effects of in vivo administration of anti-IL-10 monoclonal antibody on the host defence mechanism against murine Salmonella infection. Immunology 1995; 85:381-8.
30. Tonetti L, Spaccapelo R, Cenci E et al. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur J Immunol 1995; 25:1559-65.
31. Romani L, Pucetti P, Mencacci A et al. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 1994; 152:3514-21.
32. Park DR, Skerrett SJ. IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-γ: differential responses of blood monocytcs and alveolar macrophages. J Immunol 1996; 157:2528-38.
33. Denis M, Ghadirian E. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J Immunol 1993; 151:5425-30.
34. Bermudez LE, Champsi J. Infection with Mycobacterium avium induces production of interleukin-10, and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun 1993; 61:3093-7.
35. Sawa T, Corry DB, Gropper MA et al. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immunol 1997; 159:2858-66.
36. Hunter CA, Ellis-Neyes LA, Slifer T et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 1997; 158:3311-6.
37. Abrahamsohn IA, Coffman RL. Trypanosoma cruzi: IL-10, TNF, IFN-γ, and IL-12 regulate innate and acquired immunity to infection. Exp Parasitol 1996; 84:231-44.
38. Never LE, Grunig G, Fort M et al. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect Immun 1997; 65:1675-82.
39. Gazzinelli RT, Wysocka M, Hieny S et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α. J Immunol 1996; 157:798-805.
40. Linke A, Kuhn R, Muller W et al. Plasmodium chabandi chabandi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp Parasitol 1996; 84:253-63.
41. Bambirra EA, da Cruz MQ, Campos DS et al. Some characteristics of the hyperreactivity to bacterial lipopolysaccharide induced in mice by Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 1994; 79:433-7.
42. Kierszenbaum F, Saavedra LE. The effects of bacterial endotoxin on the infection of mice with Trypanosoma cruzi. Protozool 1972; 19:655-7.
43. Howard M, Muchamuel T, Andrade S et al. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993; 177:1205-8.